Home › Trial NCT01467310
Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212
- Trial IDNCT01467310
- StatusCompleted
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorUNC Lineberger Comprehensive Cancer Center
- Enrollment15
- Start date2012-01
- ConditionsBreast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.